ORAI1 mutation with mixed loss and gain of function properties causes immunodeficiency and HLH

ORAI1 基因突变兼具功能丧失和功能获得两种特性,可导致免疫缺陷和噬血细胞性淋巴组织细胞增生症 (HLH)。

阅读:10
作者:Lucile Noyer ,Priscilla S-W Yeung ,Sascha Kahlfuss ,Catherine Li Lai ,Maxwell McDermott ,Devisha Patel ,Jun Yang ,Yin-Hu Wang ,Li Zhong ,Peter Hsu ,Murali Prakriya ,Stefan Feske

Abstract

Loss of function mutations of ORAI1 suppress store-operated Ca2+ entry (SOCE) and cause an immunodeficiency disorder called Ca2+ release-activated Ca2+ (CRAC) channelopathy. Here we report an infant patient who is compound heterozygous for p.His134Pro and p.Leu194Pro mutations in ORAI1 and whose T cells have strongly reduced SOCE. Whereas the p.Leu194Pro mutant ORAI1 protein is not expressed at the plasma membrane, the p.His134Pro mutation results in a constitutively open channel that is unresponsive to activation by stromal interaction molecule 1 (STIM1). The patient suffered from a severe form of combined immunodeficiency (CID), hemophagocytic lymphohistiocytosis (HLH) and fatal chronic cytomegalovirus infection. His immunodeficiency was characterized by an altered composition of T and NK cell compartments, impaired stimulation-induced cytokine production and signs of CD4+ T cell and NK cell activation but attenuated CD8+ T effector memory cell function. Our findings demonstrate that small constitutive SOCE through a mutant ORAI1 channel is not sufficient to provide immunity to viral infection.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。